Literature DB >> 21858661

FAN1 variants identified in multiple-case early-onset breast cancer families via exome sequencing: no evidence for association with risk for breast cancer.

Daniel J Park1, Fabrice A Odefrey, Fleur Hammet, Graham G Giles, Laura Baglietto, John L Hopper, Daniel F Schmidt, Enes Makalic, Olga M Sinilnikova, David E Goldgar, Melissa C Southey.   

Abstract

We are interested in the characterisation of previously undescribed contributions to the heritable component of human cancers. To this end, we applied whole-exome capture, followed by massively parallel sequence analysis to the germline DNA of two greater than third-degree affected relatives from four multiple-case, early-onset breast cancer families. Prior testing for variants in known breast cancer susceptibility, genes in these families did not identify causal mutations. We detected and confirmed two different variants in the DNA damage repair gene FAN1 (R377W, chr15:31197995 C>T and R507H, chr15:31202961 G>A [hg19]) which were not present in dbSNP131. In one family, FAN1 R377W, predicted to be damaging by SIFT and PolyPhen2, was present in all six tested members with cancer (five with breast cancer, one with malignant melanoma). In another family, FAN1 R507H, predicted to be damaging by SIFT but benign by PolyPhen2, was observed in one of two tested members with breast cancer. We genotyped FAN1 R377W and R507H variants across 1417 population-based cases and 1490 unaffected population-based controls (frequency-matched for age). These variants were rare in the Australian population (minor allele frequencies of 0.0064 and 0.010, respectively) and were not associated with breast cancer risk (OR = 0.80, 95% CI[0.39-1.61], P = 0.50 and OR = 0.74, 95% CI[0.41-1.29], P = 0.26, respectively). Analysis of breast cancer risks for relatives of case and control carriers did not find evidence of an increased risk. Despite the biological role of FAN1, the plausibility of its role as a breast cancer predisposition gene, and the possible deleterious nature of the identified variants, these two variants do not appear to be causal for breast cancer. Future studies to extend the genetic analysis of FAN1 will further explore its possible role as a breast cancer susceptibility gene.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21858661     DOI: 10.1007/s10549-011-1704-y

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  7 in total

1.  Cancer genomics and inherited risk.

Authors:  Zsofia K Stadler; Kasmintan A Schrader; Joseph Vijai; Mark E Robson; Kenneth Offit
Journal:  J Clin Oncol       Date:  2014-01-21       Impact factor: 44.544

2.  The future of clinical cancer genomics.

Authors:  Kenneth Offit
Journal:  Semin Oncol       Date:  2016-10-18       Impact factor: 4.929

3.  Genetic and Functional Analyses Point to FAN1 as the Source of Multiple Huntington Disease Modifier Effects.

Authors:  Kyung-Hee Kim; Eun Pyo Hong; Jun Wan Shin; Michael J Chao; Jacob Loupe; Tammy Gillis; Jayalakshmi S Mysore; Peter Holmans; Lesley Jones; Michael Orth; Darren G Monckton; Jeffrey D Long; Seung Kwak; Ramee Lee; James F Gusella; Marcy E MacDonald; Jong-Min Lee
Journal:  Am J Hum Genet       Date:  2020-06-25       Impact factor: 11.025

Review 4.  A Systematic Literature Review of Whole Exome and Genome Sequencing Population Studies of Genetic Susceptibility to Cancer.

Authors:  Alisa M Goldstein; Elizabeth M Gillanders; Melissa Rotunno; Rolando Barajas; Mindy Clyne; Elise Hoover; Naoko I Simonds; Tram Kim Lam; Leah E Mechanic
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-05-28       Impact factor: 4.254

5.  Rare mutations in RINT1 predispose carriers to breast and Lynch syndrome-spectrum cancers.

Authors:  Daniel J Park; Kayoko Tao; Florence Le Calvez-Kelm; Tu Nguyen-Dumont; Nivonirina Robinot; Fleur Hammet; Fabrice Odefrey; Helen Tsimiklis; Zhi L Teo; Louise B Thingholm; Erin L Young; Catherine Voegele; Andrew Lonie; Bernard J Pope; Terrell C Roane; Russell Bell; Hao Hu; Chad D Huff; Jonathan Ellis; Jun Li; Igor V Makunin; Esther M John; Irene L Andrulis; Mary B Terry; Mary Daly; Saundra S Buys; Carrie Snyder; Henry T Lynch; Peter Devilee; Graham G Giles; John L Hopper; Bing-Jian Feng; Fabienne Lesueur; Sean V Tavtigian; Melissa C Southey; David E Goldgar
Journal:  Cancer Discov       Date:  2014-05-02       Impact factor: 39.397

6.  Effect of Next-Generation Exome Sequencing Depth for Discovery of Diagnostic Variants.

Authors:  Kyung Kim; Moon-Woo Seong; Won-Hyong Chung; Sung Sup Park; Sangseob Leem; Won Park; Jihyun Kim; KiYoung Lee; Rae Woong Park; Namshin Kim
Journal:  Genomics Inform       Date:  2015-06-30

Review 7.  Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification.

Authors:  Rick Kamps; Rita D Brandão; Bianca J van den Bosch; Aimee D C Paulussen; Sofia Xanthoulea; Marinus J Blok; Andrea Romano
Journal:  Int J Mol Sci       Date:  2017-01-31       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.